Neurocognitive Function Improvement After Switching From Efavirenz to Rilpivirine

Clinical trial NCT03567304 · UNKNOWN

Trial details

NCT number: NCT03567304
Sponsor: Chiang Mai University
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

HIV-1-infection Neurocognitive Dysfunction

Start date: 2018-07-06
Primary completion: 2020-07-01
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.